版本:
中国

BRIEF-Impax announces FDA approval and launch of a generic version of vytorin

April 26 Impax Laboratories Inc:

* Impax announces FDA approval and launch of a generic version of vytorin (ezetimibe/simvastatin tablets)

* Impax Laboratories Inc - received final FDA approval for a generic version of vytorin and immediately initiated commercialization activities Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐